期刊文献+

抑荨止痒汤联合氯雷他定治疗慢性荨麻疹疗效观察 被引量:1

Clinical observation on treating chronic urticarial by the Yixun Zhiyang decoction combined with loratadine
下载PDF
导出
摘要 目的:观察抑荨止痒汤联合氯雷他定治疗慢性荨麻疹的临床疗效。方法:78例患者随机分为治疗组38例和对照组40例。治疗组口服抑荨止痒汤联合氯雷他定治疗,对照组口服氯雷他定治疗,两组均连续治疗30d为1个疗程。观察两组1个月疗程内的疗效及随访2个月内临床复发情况。结果:治疗1个月后,治疗组总有效率为92.11%,对照组的总有效率为75%,治疗组总有效率明显优于对照组(P<0.05)。随访2个月后,治疗组18例痊愈患者中有6例复发,对照组10例痊愈患者中有6例复发,两组对照有显著差异(P<0.05)。结论:抑荨止痒汤联合氯雷他定治疗慢性荨麻疹疗效高、安全性好,且能有效地控制复发。 Objective:To observe the clinical efficacy of the Yixun Zhiyang decoction combined with loratadine on treating chronic urticarial. Methods:78 cases were randomly divided into the treated group (38 cases) and the control group (40 cases). The treated group was given the Yixun Zhiyang decoction combined with loratadine, the control group was treated with loratadine treatment, and 30 days for a course, the efficacy within a treatment course and clinical recurrence situation within two months of the two groups were observed. Results: After 1 month of treatment, the total efficency of the treaed group was 92.11%, and was 75%of the control group, the treated group was better (P〈0.05). Follow-up two months later, in treated group, 18 cases were cured, 6 patients relapsed, the control group of 10 patients were cured patients, 6 patients relapsed, There were significant differencesbetween two groups (P〈0.05). Conclusion:The Yixun Zhiyang decoction combined with loratadine was effective on treating chronic urticaria, safety, and can effectively control the recurrence.
作者 游俊
机构地区 江汉大学医学院
出处 《中医临床研究》 2014年第4期49-50,共2页 Clinical Journal Of Chinese Medicine
关键词 抑荨止痒汤 氯雷他定 慢性荨麻疹 Yixun Zhiyang decoction Loratadine Chronic urticarial
  • 相关文献

参考文献3

  • 1赵辨.临床皮肤病学[M].4版.南京:江苏科学技术出版社,2003:615-619.
  • 2刘玲玲,朱学骏,姜薇,陈喜雪,李明,彭振辉,郭在培,李福秋.咪唑斯汀治疗慢性荨麻疹的随机双盲研究[J].中华皮肤科杂志,2003,36(6):306-309. 被引量:149
  • 3张志礼.皮肤病临床经验辑要[M].北京:中国医药科技出版社,2000.205-206.

二级参考文献7

  • 1张宏誉,李宏,岳凤敏,王良录,方权,王瑞琦,秦万章,李明,金岚,秦立模,吴惠俐.咪唑斯汀治疗慢性特发性荨麻疹的多中心随机平行组对照的临床试验报告[J].中华微生物学和免疫学杂志,2001,21(S2):61-64. 被引量:11
  • 2Pichat P;Angel I;Arbilla S.Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat,1998(01).
  • 3Benavides J;Schoemaker H;Dana C.In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent,1995.
  • 4Dubertr;Murrieta Aguttes M;Tonet J.Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria:results of the MILOR Study[J],1999.
  • 5Sabbah A;Daele J;Wade AG.Comparison of the efficacy,safety,and onset of action of mizolastine,cetirizine,and placebo in the management of seasonal allergic rhinoconjunctivitis.MIZOCET Study Group[J],1999.
  • 6Leynadier F;Duarte-Risselin C;Murrieta M.Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria URTILOR study group,2000.
  • 7朱大勋.咪唑斯汀和四种常用H_1受体阻滞剂的实验抗组胺强度比较[J].中华皮肤科杂志,2001,34(3):219-220. 被引量:36

共引文献163

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部